Pulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE) to a sell rating in a report published on Friday morning.

Pulse Biosciences Stock Performance

NASDAQ PLSE opened at $17.32 on Friday. The stock’s fifty day moving average is $17.58 and its two-hundred day moving average is $12.70. The firm has a market capitalization of $956.50 million, a P/E ratio of -21.38 and a beta of 1.75. Pulse Biosciences has a fifty-two week low of $3.78 and a fifty-two week high of $22.69.

Institutional Investors Weigh In On Pulse Biosciences

Hedge funds have recently modified their holdings of the company. PNC Financial Services Group Inc. acquired a new position in Pulse Biosciences in the 4th quarter valued at about $242,000. Griffin Asset Management Inc. grew its position in Pulse Biosciences by 15.7% in the first quarter. Griffin Asset Management Inc. now owns 300,320 shares of the company’s stock worth $2,616,000 after acquiring an additional 40,700 shares during the period. BNP Paribas Financial Markets increased its stake in Pulse Biosciences by 63.6% during the first quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock worth $66,000 after acquiring an additional 2,952 shares during the last quarter. Inspire Investing LLC raised its position in Pulse Biosciences by 32.1% in the first quarter. Inspire Investing LLC now owns 41,358 shares of the company’s stock valued at $360,000 after purchasing an additional 10,039 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of Pulse Biosciences by 28.8% in the 1st quarter. Vanguard Group Inc. now owns 847,212 shares of the company’s stock valued at $7,379,000 after purchasing an additional 189,227 shares during the last quarter. Hedge funds and other institutional investors own 76.95% of the company’s stock.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.